Gemcitabine-O-Si(di-iso)-O-Mc is a drug-linker conjugate for ADC with potent antitumor activity by using Gemcitabine (a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent; HY-17026), linked via the ADC linker.
Structure of
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Gemcitabine-O-Si(di-iso)-O-Mc is a synthetic derivative of the antineoplastic agent gemcitabine, meticulously crafted to elevate its efficacy and delivery. Here are four key applications of this innovative compound:
Chemotherapy: Gemcitabine-O-Si(di-iso)-O-Mc plays a pivotal role in chemotherapy regimens targeting a spectrum of cancers like pancreatic, lung, and breast cancer. Its advanced delivery system ensures optimized drug concentrations reach malignant cells, amplifying therapeutic effectiveness. This tailored approach not only fosters superior treatment outcomes but also holds the promise of mitigating adverse effects linked to conventional gemcitabine therapy.
Targeted Drug Delivery: By transforming gemcitabine into Gemcitabine-O-Si(di-iso)-O-Mc, researchers unlock the potential for tailored drug delivery systems. These systems precisely guide the drug to cancerous cells, minimizing harm to healthy tissues. Such targeted precision not only augments therapeutic efficacy but also diminishes systemic toxicity.
Drug Combination Studies: Exploration of Gemcitabine-O-Si(di-iso)-O-Mc in synergy with other chemotherapeutic agents unveils the potential for enhanced anticancer effects. Combining this derivative with complementary drugs may synergistically elevate overall efficacy and surmount resistance mechanisms.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.